Skip to search formSkip to main contentSkip to account menu

Insulin, Glulisine, Human

Known as: insulin, Lys(B3)-Glu(B29)-, glulisine insulin, INSULIN GLULISINE 
A drug used to control the amount of sugar in the blood of patients with diabetes mellitus. It is a form of the hormone insulin that is made in the… 
National Institutes of Health

Related topics

Related topics

13 relations
3 ML Insulin, Glulisine, Human 100 UNT/ML Pen Injector3 ML Insulin, Glulisine, Human 100 UNT/ML Pen Injector [Apidra]Decreased Lipolysis [PE]Diabetes Mellitus, Insulin-Dependent

Narrower (1)

Apidra

Broader (2)

Hypoglycemic AgentsInsulin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trials
This study aimed to identify population/regional differences in drug efficacy and the influencing factors among East Asians to be… 
2015
2015
Effects of rapid-acting insulin analogues insulin glulisine and insulin aspart on postprandial glycemic excursion with single bout of exercise in patients with type 2 diabetes.
The analogue insulin glulisine (Glu) shows both more rapid onset and shorter duration of action compared with the other rapid… 
2014
2014
The addition of metformin and glucagon-like peptide-1 receptor agonist or dipeptidyl-peptidase-4 inhibitor to insulin for latent autoimmune diabetes in adults
Dear Sir, Latent autoimmune diabetes in adults (LADA) is considered to be a form of autoimmune diabetes that resembles type 1… 
2013
2013
Insulin Glulisine May Cause a Disease Resembling Insulin Autoimmune Syndrome: Case Report
Insulin autoimmune syndrome (IAS) is a rare cause of spontaneous hypoglycemia with severe hyperinsulinemia characterized by high… 
Review
2012
Review
2012
Insulin analogues for type 1 diabetes in children and adolescents.
Since insulin is the unique and life-long therapy in type 1 diabetes and classical insulin preparations have certain limitations… 
2009
2009
Dose–response relationship of insulin glulisine in subjects with type 1 diabetes
Aim:  Little is known about the dose–response relationships of rapid‐acting insulin analogues in subjects with diabetes. This… 
Review
2009
Review
2009
Preoperative hypoglycemia in a patient receiving insulin detemir.
The insulin regimen of a Type 2 diabetic presenting for surgery had been changed recently from a 70/30 mixture of insulin aspart… 
Review
2006
Review
2006
Newer insulin analogues and inhaled insulin.
Diabetes is a metabolic disease with high prevalence worldwide. Exogenous insulin is used in the management of this condition… 
2005
2005
Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors
Aims/hypothesisNew insulin analogues have been created by amino-acid exchange to provide an improved pharmacokinetic profile… 
Review
2003
Review
2003
Insulin glulisine. Aventis Pharma.
Aventis Pharma (formerly Hoechst Marion Roussel) is developing insulin glulisine, a fast-acting insulin analog, for the potential… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)